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Summary To assess how women regard having had a false positive mammogram screening exam, and the
influence that this had on their quality of life, 126 such women were interviewed. Their responses were
compared to those of 152 women randomly selected among screenees with a negative exam. Eighteen months
after the screening the reported prevalence ofanxiety about breast cancer was 29% among women with a false
positive and 13% among women with a negative screening mammogram (P = 0.001). Of 30 women biopsied, 8
(27%) had pain in the breast and 10 (33%) had reduced sexual sensitivity. A false positive mammogram was
described by 7 (5%) of the women as the worst thing they ever had experienced. However, most women with a
false positive result regarded this experience, in retrospect, as but one of many minor stressful experiences
creating a temporary decrease in quality of life. They report the same quality of life today as women with
negative screening results and 98% would attend another screening. Even so, false positive results are a matter
of concern, and efforts should be made to minimise this cost whenever a screening programme is conducted.
The reduced breast cancer mortality found in several major
studies (Shapiro et al., 1982; Collette et al., 1984; Verbeek et
al., 1984; Tabar et al., 1985, 1989; Palli et al., 1986) is the
rationale for screening with mammography. In order to jus-
tify the continued use of a screening procedure, subjects
correctly classified as positive at screening should receive a
benefit. However, the magnitude of the reduction in breast
cancer resulting from screening has been questioned, and
issues regarding adverse effects of breast screening have been
raised (Skrabanak, 1985, 1988; Wright, 1986; Eddy, 1988;
Devitt, 1989).
So far, breast screening has not been found to increase
psychiatric morbidity as measured by the General Health
Questionnaire, neither among women with negative (Dean et
al., 1986) nor false positive screening results (Ellman et al.,
1989). In the Canadian National Breast Screening Study
(Baines et al., 1990) 93% of the women, receiving either
annual mammography or physical examinations for three or
four years, reported this as a positive experience. Women's
attitudes and expectations based upon their own experiences
are important aspects of the screening issue that need to be
addressed further. This study set out to investigate how
women regard having had a false positive result at a
mammography screening, and whether the experience has
consequences for their attitude toward mammography and
long-term quality of life.
Materials and methods
Screening/work-up examination
The mammography screening was a part of a health survey
carried out in Troms6, Norway 1986/87. Women aged 40 or
older (n = 4,323), were offered a free mammogram, and 85%
of these women had their mammogram taken. The women
were told that only those with an abnormal mammogram
would be notified by mail within three weeks. Altogether 193
(5%) of the screenees were selected for a work-up mammog-
raphic examination, and of these 61 were subsequently refer-
red to a surgeon. Altogether 40 (1%) women underwent
biopsy, mostly as hospital inpatients, and ten new cases of
breast cancer were diagnosed. Details of the screening and
case finding procedures are given elsewhere (Gram et al.,
1989). Fourteen women were ineligible for the present study
(two lost to migration before work-up, ten with a new and
two with a previous diagnosis of breast cancer). The remain-
ing 179 women with a false positive screening result formed
the study group.
Questionnaire
A questionnaire concerning attitudes toward mammography,
anxiety about having breast cancer and a request for a future
interview were mailed to the study group six months after the
screening mammogram. The questionnaire was also mailed to
the following three groups: a random sample of 250 women
selected from women with a negative screening result
(reference sample), a random sample of 250 women not
invited to screening living in the nearby city of Harstad
(population sample) and women invited who did not attend
(non-attenders, n = 670) (Figure 1). In the study group 89%
completed the questionnaire. The corresponding completion
rates for the eligible women in the reference group was 84%,
among non-attenders 43%, and in the population sample
66%. Women completing the questionnaire although
migrated (n = 31, non-attenders) are included in the analysis.
The women in the combined comparison groups were within
the same age range.
Interview
Women in the study and reference group who had indicated
that they would allow an interview were contacted about
year after returning their questionnaire. Women who did not
show up were mailed a new time for appointment. Those still
not responding were approached by telephone and their
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Figure 1 Flow chart of the mammography screening in Tromso,
Norway 1986/87 and questionnaire response status among the
four comparison groups.
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reason for lack of response sought. All women were inter-
viewed in person by one of four female interviewers.
The interview comprised open-ended, dichotomous, scaled
and paired comparison questions. Two cards showing
different alternatives were handed the respondent when com-
parisons were used. Members of the study group were asked
to recall the time interval between being informed of their
abnormal mammogram result and the subsequent notifica-
tion of their results from the work-up. For brevity this period
is referred to in the text as the work-up period. Members of
the reference group were asked to recall the 3 weeks sub-
sequent to the screening, when they did not know the result
of their screening mammogram. For brevity this period is
referred to in the text as the screening period. As an
indicator of well-being a ladder scale with ten rungs, derived
from the Self Anchoring Scale of Hadley Cantril (Cantril,
1965) was used. The top rung was labelled 'Best life I could
expect to have' and the bottom rung 'Worst life I could
expect to have'. The respondents were asked to rate them-
selves today. Afterwards, the study group rated themselves in
the work-up period and the reference group in the screening
period. The study group was questioned as to whether they
would be willing to go through a similar work-up if it were
free, or to pay any amount of money to get a reviewed and
final result of the screening mammogram the next day with-
out further assessments, assuming this was technically feasi-
ble. The reference group cited what they would pay to get the
result of the screening mammogram the following day. As an
indicator of willingness to trade longevity for quality of life,
some questions derived from the proportional trade-off
method were used (Weinstein et al., 1980). Members of the
study group were asked if they would trade-off, in the follow-
ing order, 21, 1, 7, or 14 of their last days of life (assuming a
life-span of 79 years and remaining healthy) to avoid going
through the work-up period. Women in the reference group
were asked the same question regarding the screening period.
Spontaneous comments on the different questions were
recorded. The women were encouraged to talk freely at the
end of the interview which took about 30 min to complete.
The analyses were performed using the Pearson x2 statistic
and t test procedures available in the SAS statistical package
(SAS Version 6). Results were considered statistically signi-
ficant with a P value of 0.05 or less.
Results
Analysis of questionnaire responses 6 months after the
screening revealed a prevalence of anxiety about breast
cancer in the study group of 40% and in the reference group
of 22% (P<0.001) (Table I). The corresponding prevalence
was 21% in the non-attenders group and 33% in the popula-
tion group. The latter was significantly higher compared with
the reference group (P = 0.03). Eighteen months after the
screening the prevalence of anxiety about breast cancer was
29% in the study group and 13% in the reference group
(P = 0.001).
Among the women completing the questionnaire 90% in
the study group and 88% in the reference group indicated
their willingness to be interviewed (Table II). When invited,
88% of the former and 83% of the latter group attended.
Table III shows that the two groups were similar with respect
to a number of selected characteristics at the time of the
mammography screening.
Neither of the groups interviewed had changed their fre-
quency of visits to health professionals during the preceding
year, compared to what they reported at the time of the
screening. No significant differences were found between the
study and reference groups with respect to their being easily
worried, suffering from sleeplessness, taking sleeping pills or
sedatives, or frequency of breast self-examination (results not
shown in tables).
Table IV shows that both groups had an average state of
well-being of 7.7 on the Ladder scale at the time of the
interview. The study group recalled a significant decrease in
Table I Prevalence ofanxiety about breast cancer reported by group
according to questionnaire and interview
Prevalence (%)
Group (95% CI) x2
Questionnaire 6 months Study 40 (32-48) 12.6'**
after screening (n = 151)
Reference 22 (17-28)
(n = 206)
Non-attenders 21 (16-27) 0.1 n.s.
(n = 230)
Population 33 (26-40) 5.0'
(n = 155)
Interview 18 months after Study 29 (21-37) 10.2**
screening (n = 126)
Reference 13 (7-18)
(n= 152)
n.s. Not significantly different from reference group. 'Significantly
different from reference group (P = 0.03). **Significantly different from
reference group (P = 0.001). "'Significantly different from reference
group (P<0.001).
Table II Interview response status (%) of women completing the
questionnaire by group
Group
Study Reference
(n = 160) (n = 209)
Response status % %
Declined 16 (10) 26 (12)
Not attended 18 (11) 31 (15)
Attended 126 (79) 152 (73)
Table III Selected attributes for women in study and reference group
at the time of the screening given as mean (s.e.) or per cent (%)
Group'
Study Reference
n= 126 n= 152
Age (years) 46.4 (0.4) 47.2 (0.4)
Years of education 9.9 (0.3) 10.0 (0.3)
Number of children 2.3 (0.1) 2.6 (0.1)
Married (%) 83 85
Full time work (%) 54 48
Children under 10 years (%) 12 16
Health condition well (%) 81 73
Headache monthly or more (%) 51 50
Able to cope with problems last two 82 80
weeks if any (%)
Visits last year to
general practitioner 1.6 (0.2) 1.6 (0.1)
outpatient department 0.6 (0.1) 0.5 (0.1)
physiotherapist 1.8 (0.5) 2.1 (0.5)
aSome values are based on fewerthan thetotal numberdue tomissing
values.
Table IV Average state ofwell-being reported on the Ladder Scale at
time of interview and during work-upa and screeningb period by
group
Group
Study Reference
Time period (n = 126) (n = 152)
Interview 7.7 7.7
Result unknown 55a* 7.2b n.s.
aInterval between being informed of their abnormal mammogram
result and subsequent notification of their result from the work-up.
"Three weeks subsequent to the screening, when they did not know the
result oftheir screeningmammogram. *Significantlydifferent from time
of interview (P<0.001). n.s., Not significantly different from time of
interview.1020 I.T. GRAM et al.
Table V Women (%) in study and reference group considering listed
minoreventstobemorestressful tothemthanrespectively thework-upa
and screeningb period
Group
Study
Biopsy Reference
yes no
(n =29) (n = 94) (n = 152)
Minor events % % %
Headache one day 24* 60* 83
Gastric flu one day 38* 69* 95
Rain three weeks of vacation 38* 74* 97
Sprain the ankle 41* 72* 98
'Interval between being informed of their abnormal mammogram
result and subsequent notification of their result from the work-up.
"Three weeks subsequent to the screening, when they did not know the
result of their screening mammogram. 'Significantly different from
reference group (P<0.001).
Table VI Highest amount of money ($) the women would pay to
attend another mammography screening given as mean (s.e.) and
median (range), by group
Group
Study
Biopsy Reference
yes no
Amount ofmoney in US (n = 30) (n = 94) (n = 147)
dollars $ $ $
Mean (s.e.) 60 (12) 70' (9) 46 (4)
Median (range) 32 (0-286) 43 (0-429) 29 (0-143)
'Significantly different from reference group (P = 0.02).
Table VII Highest amount ofmoney ($) the women would pay to get
the results ofthe work-up' and screeningb the next day, given as mean
(s.e.) and median by group
Group
Study
Biopsy Reference
yes no
Amount ofmoney in US (n = 30) (n = 91) (n = 152)
dollars $ $ $
Mean (s.e.) 66 (12)' 32 (6)' 10 (2)
Median (range) 29 (0-286) 14 (0-429) 0 (0-143)
'Get areviewedandfinalresultofthescreeningmammogramthe next
day without further assessments. bGet the result of the screening
mammogram the nextday. 'Significantlydifferent from referencegroup
(P<0.001).
Table VIII Women (%) reporting how many days oftheir livesa they
would trade off in exchange for not experiencing the work upb or
screeningc period another time, by group
Group
Study
Biopsy Reference
yes no
(n=29) (n = 93) (n = 148)
No. ofdays % % %
None 24* 35* 69
1,7,14 10 11 7
21 66* 54* 24
'Assuming a life-span of 79 years and remaining healthy. bInterval
between being informed of their abnormal mammogram result and
subsequent notification of their result from the work-up. cThree weeks
subsequent to the screening, when they did not know the result oftheir
screening mammogram. 'Significantly different from reference group
(P<0.0001).
their state of well-being during the work-up period
(P = 0.0001). A slight decrease in well-being reported by the
reference group was not statistically significant.
In the study group 95 (80%) of 118 indicated the duration
of the work-up period to be 4 weeks or less. The women's
perceptions of the length of the work-up period was longer
than that documented in the hospital files (Wilcoxon signed
rank test, P = 0.05). Eighty (63%) of the women reported
that they had been anxious during the work-up period.
Among them 14 (11%) claimed they had less capacity for
work until learning the result of the work-up, while 19 (15%)
reported they had this problem only on some days. In the
reference group 24 (16%) said they were anxious about the
result of their screening mammogram, and one of them
reported having less capacity for work because of this anx-
iety.
Thirty-one per cent in the study group and 38% in the
reference group considered themselves to be frequently sub-
jected to stress (P = 0.3). Events occurring within the family
such as death, serious disease, conflicts and major accidents
were incidents perceived by the study group to involve more
strain than the work-up period. Having a pelvic examination,
visiting a dentist and waiting for medical test results were
situations most frequently described as subjecting them to a
degree of stress similar to that of the work-up period. Six
(5%) of 117 women said they had never suffered anything
worse than having a false alarm at the mammography screen-
ing. Five of these women had undergone biopsy. However,
all six said they would attend another screening with
mammography.
Table V shows that about 40% of biopsied women
regarded minor stressful events such as suffering from gastric
flu or spraining an ankle as probably causing them more
inconvenience and stress than the work-up period did.
Among women not having a diagnostic biopsy about 70%
considered the mentioned events as probably more traumatis-
ing than the work-up period was. Most of the women, but
not all, in the reference group considered the screening
period as less stressful than the events they compared it to.
Women in the study group not biopsied were on the
average, willing to pay $70 to attend another screening
(Table VI). This was $10 more than the women biopsied were
willing to pay (P = 0.5) and $24 more than women in the
reference group were willing to pay (P = 0.02). While answer-
ing this question, many women made their own comparison
saying they would pay a cost equal to that of a visit to a
physician ($7), to a dentist ($70) or of a car repair ($150).
Table VII shows that biopsied women would be willing to
pay the highest amount of money ($66) to get the result of
the examination the next day without any further assess-
ments. Only one of the women biopsied was willing to pay
more than $150 to avoid this experience again. In the
reference group 100 (66%) claimed that they would rather
wait for 3 weeks than pay anything to get the result the next
day.
However, as shown in Table VIII, 76% of biopsied women
reported to be willing to trade off days of their lives in the
future, assuming this could spare them another work-up
period. Among the women in the study group not subjected
to surgery 65% were willing to trade off days of life to avoid
the work-up period. In the reference group 31% said they
would trade off days of life in exchange;for having the result
of the screening mammogram the next day.
Of the 30 women who underwent biopsy, eight (27%) had
pain from the scar, while ten (33%) had reduced sexual
sensitivity in the breast. Three (2%) women described that
having a false alarm at the screening subsequently had an
overall bad influence on their lives. For two of them this was
due to trouble from the scar caused by surgery. The third
woman said she had become more anxious about breast
cancer. In the study group 44% claimed that the experience
of going through the screening and the work-up had an
overall positive impact on their lives. However, these women
said more often than the rest of the study group that they
had been anxious in the work-up period (P = 0.04). In the
reference group 53% claimed that the mammography screen-
ing had an overall positive impact on their lives. The remain-
ing women in both groups considered these experiences of
minor significance and reported no overall impact. Only three
(1%) of 278 women did not want to participate if they wereQUALITY OF LIFE AFTER FALSE POSITIVE MAMMOGRAM 1021
again offered a free screening with mammography, while
another 11 (4%) said they would not attend if they had to
pay.
Discussion
This study shows that most women with a false positive
result at a mammography screening regard this experience, in
retrospect, as but one of many minor stressful experiences in
their lives. It also demonstrates that these women are in
favour of attending another screening, and that they report
the same quality of life today as women with negative screen-
ing results.
One long-term adverse effect found in this study is the
physical morbidity, i.e. pain and reduced sexual sensitivity
described by some of the women subjected to surgery. This
negative impact on sexuality was also commented on by
some of the women participating in the Canadian study
(Baines et al., 1990).
Another effect found in our study is that women with a
false positive screening result have a higher prevalence of
anxiety about breast cancer compared with women with a
negative screening mammogram. The high prevalence of anx-
iety about breast cancer reported by the population group
not exposed to mammography screening indicates that this
anxiety is widespread in the general population. The results
from the questionnaire suggest that the screening is
generating an increase in this prevalence among women in
the false positive group and a decrease among women in the
negative result group. Time seems to have an impact on level
of anxiety about breast cancer, since both groups have a
decreased prevalence at 18 months compared with 6 months
after the screening. Of the women attending Edinburgh
Breast Screening Clinic (Dean et al., 1986) 40% said they
sometimes worried about the possibility of having breast
cancer before the screening. This proportion did not change 6
months after the screening. Among women attending the
screening program in Canada (Baines et al., 1990) for 3 or 4
years, only 5% reported being anxious and another 5% that
this varied. Sixty-one per cent of the women offering ex-
planations for their anxiety said it was because they had been
referred to the review clinic. In spite of this, the responses to
the question about anxiety induced by screening, were not
found to differ significantly by review status.
In our study it is noteworthy that women willing to pay
the highest amount of money to attend another screening are
found among those who experienced a positive screening test,
but who did not go through diagnostic surgery. It is also
notable that a substantial proportion of the study group
reported that this experience had a positive impact on their
lives. Some of them stated explicitly that they were grateful
for this experience, because they found life more precious
afterwards. However, it seems unreasonable to put this on
the positive side of the balance sheet of a screening, since first
the fear, then the relief, are induced by the same screening.
Nevertheless, the data suggest that women correctly classified
as negative have gained a benefit from the screening, as the
majority report that the screening had an overall positive
impact on their lives.
With regard to the question of trading longevity, an incon-
sistency appeared. That is, some biopsied women would
rather go through another operation than trade a single day
in the future, while others were willing to trade 3 weeks of
their lives in exchange for having the screening result the next
day. In our survey, answers to these questions do not seem to
reflect what they were intended to measure, that is how much
stress the women had been through. It rather reflects main
differences in attitude toward longevity. The following two
viewpoints emerged from spontaneous comments during the
interview. When an age of 79 years was assumed, it mattered
little to the women if they were alive 21 days more or less.
The other one was that if healthy, even I day that far away
was too much to trade to avoid a reduction in quality of life
today.
The fact that women recalled the duration of the work-up
period to be longer than it probably was, can be interpreted
as an indirect measure of the unpleasantness of the work-up
period. This difference, however, may also be explained by
missing information on later visits in the hospital files.
Since the purpose of this investigation was to focus on the
consequences that a false positive result has on women atten-
ding a screening, subjects with a negative mammogram result
were chosen as a reference group. This is not fully satisfac-
tory since the two groups have to compare different
experiences when answering some of the questions. The inter-
view method was selected to allow observation of how the
women responded to the questions. Based on hypothetical
situations, some answers depend on the women's ability to
abstract comparisons. A potential weakness of the method
applied is the possible risk of bias due to the attitudes of the
interviewers. An interesting observation is that all women
subjected to surgery agreed to and were available for inter-
view, as opposed women not subjected to surgery. This fact
creates a selection bias toward emphasising the opinions of
biopsied women more than their true proportion among
women with false positive mammogram should imply.
The increased morbidity induced by mammography screen-
ing has led some authors advocate the abandonment (Wright,
1986) or discouragement (Devitt, 1989) of such screening
before the age of 60. This paper is an attempt to evaluate the
magnitude of this morbidity. Even if the women with a false
alarm at the screening report the same quality of life today as
do women with negative screening mammogram, our data
suggest that some of them will suffer from undesirable long-
term effects, and a small proportion will experience this as
subsequently having an overall bad influence on their lives.
Efforts should be made to minimise this cost whenever a
screening programme is conducted.
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